Literature DB >> 22046074

Primary cutaneous large B-cell lymphoma, leg type.

Vibha Thomas1, Robin Dobson, Robert Mennel.   

Abstract

Primary cutaneous large B-cell lymphoma, leg type, is a rare and aggressive neoplasm as defined by the recently updated World Health Organization-European Organization for Research and Treatment of Cancer classification of cutaneous lymphomas. We present a case of a 74-year-old woman who presented with a cutaneous lesion on her forearm. Skin biopsy revealed pathology consistent with this entity. The patient was treated with systemic chemotherapy with rituximab combined with doxorubicin, cyclophosphamide, vincristine, and prednisone. Here, we review the available literature and summarize clinical features and management of this uncommon subtype of non-Hodgkin lymphoma.

Entities:  

Year:  2011        PMID: 22046074      PMCID: PMC3205164          DOI: 10.1080/08998280.2011.11928757

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  24 in total

1.  bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related.

Authors:  F A Geelen; M H Vermeer; C J Meijer; S C Van der Putte; E Kerkhof; P M Kluin; R Willemze
Journal:  J Clin Oncol       Date:  1998-06       Impact factor: 44.544

2.  Primary cutaneous diffuse large B-cell lymphoma, leg type, with unusual clinical presentation of bluish-reddish multicolored rainbow pattern.

Authors:  Chiung-Tang Huang; Wen-Chi Yang; Yi-Chang Liu; Sheng-Fung Lin
Journal:  J Clin Oncol       Date:  2011-03-28       Impact factor: 44.544

3.  Positive serology for Lyme disease borrelias in primary cutaneous B-cell lymphoma: a study in 22 patients; is it a fortuitous finding?

Authors:  S Jelić; I Filipović-Ljesković
Journal:  Hematol Oncol       Date:  1999-09       Impact factor: 5.271

4.  Primary cutaneous follicle center cell lymphomas and large B cell lymphomas of the leg descend from germinal center cells. A single cell polymerase chain reaction analysis.

Authors:  S Gellrich; S Rutz; S Golembowski; C Jacobs; M von Zimmermann; P Lorenz; H Audring; M Muche; W Sterry; S Jahn
Journal:  J Invest Dermatol       Date:  2001-12       Impact factor: 8.551

5.  MALT and SALT: the clue to cutaneous B-cell lymphoproliferative disease.

Authors:  D N Slater
Journal:  Br J Dermatol       Date:  1994-10       Impact factor: 9.302

6.  Absence of Borrelia burgdorferi DNA in cutaneous B-cell lymphomas from the United States.

Authors:  G S Wood; N V Kamath; J Guitart; P Heald; S Kohler; B R Smoller; L Cerroni
Journal:  J Cutan Pathol       Date:  2001-11       Impact factor: 1.587

7.  Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the Highlands of Scotland.

Authors:  J R Goodlad; M M Davidson; K Hollowood; C Ling; C MacKenzie; I Christie; P J Batstone; D O Ho-Yen
Journal:  Am J Surg Pathol       Date:  2000-09       Impact factor: 6.394

8.  TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Research and Treatment of Cancer (EORTC).

Authors:  Youn H Kim; Rein Willemze; Nicola Pimpinelli; Sean Whittaker; Elise A Olsen; Annamari Ranki; Reinhard Dummer; Richard T Hoppe
Journal:  Blood       Date:  2007-03-05       Impact factor: 22.113

9.  Complete remission of a primary cutaneous B-cell lymphoma of the lower leg by first-line monotherapy with the CD20-antibody rituximab.

Authors:  B Bonnekoh; M Schulz; I Franke; H Gollnick
Journal:  J Cancer Res Clin Oncol       Date:  2002-01-25       Impact factor: 4.553

Review 10.  WHO-EORTC classification for cutaneous lymphomas.

Authors:  Rein Willemze; Elaine S Jaffe; Günter Burg; Lorenzo Cerroni; Emilio Berti; Steven H Swerdlow; Elisabeth Ralfkiaer; Sergio Chimenti; José L Diaz-Perez; Lyn M Duncan; Florent Grange; Nancy Lee Harris; Werner Kempf; Helmut Kerl; Michael Kurrer; Robert Knobler; Nicola Pimpinelli; Christian Sander; Marco Santucci; Wolfram Sterry; Maarten H Vermeer; Janine Wechsler; Sean Whittaker; Chris J L M Meijer
Journal:  Blood       Date:  2005-02-03       Impact factor: 22.113

View more
  7 in total

1.  Cutaneous lymphoma misdiagnosed as chronic lymphadenitis.

Authors:  Mircea Munteanu; Georgiana S Mohor; Flavia Baderca; Caius Solovan
Journal:  Int Wound J       Date:  2015-04-22       Impact factor: 3.315

2.  Widespread primary cutaneous diffuse large B-cell lymphoma, leg type, with nasal involvement.

Authors:  Ecem Bostan; Neslihan Akdogan; Arzu Saglam Ayhan; Sibel Ersoy Evans
Journal:  Int Wound J       Date:  2019-05-17       Impact factor: 3.315

3.  Cutaneous Large B Cell Lymphoma Involving the Duodenum and the Bile Duct: a Case Report.

Authors:  Lamine Hamzaoui; Mouna Medhioub; Amal Khsiba; Moufida Mahmoudi; Talel Badri; Mohamed Msaddak Azouz
Journal:  J Gastrointest Cancer       Date:  2019-09

4.  Primary cutaneous diffuse large B-cell lymphoma, leg type, with multiple local relapses: case presentation and brief review of literature.

Authors:  A Patsatsi; A Kyriakou; V Karavasilis; K Panteliadou; D Sotiriadis
Journal:  Hippokratia       Date:  2013-04       Impact factor: 0.471

5.  Cutaneous B cell lymphomas: Report of two interesting cases.

Authors:  Ravichandran Gurumurthy; Ranjan Kumar Mohapatra; Jose M Easow; Subhashini Mohan
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

6.  Excellent Outcome of Immunomodulation or Bruton's Tyrosine Kinase Inhibition in Highly Refractory Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type.

Authors:  Eva Gupta; Joseph Accurso; Jason Sluzevich; David M Menke; Han W Tun
Journal:  Rare Tumors       Date:  2015-12-29

7.  Diffuse Large B Cell Lymphoma with Extensive Cutaneous Relapse.

Authors:  Umit Yavuz Malkan; Gursel Gunes; Okan Yayar; Haluk Demiroglu
Journal:  Case Rep Med       Date:  2015-09-20
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.